Jul 22, 2023 · People with obesity are more likely to develop a number of potentially serious health problems, including: Heart disease and strokes. Obesity makes you more likely to have high blood pressure and unhealthy cholesterol levels, which are risk factors for heart disease and strokes. Type 2 diabetes.

Jul 22, 2023 · The goal of obesity treatment is to reach and stay at a healthy weight. This improves overall health and lowers the risk of developing complications related to obesity.

Body mass index (BMI) uses weight and height to estimate body fat. A high BMI and large waist size may signal an increased risk of heart disease.

Nov 11, 2024 · The Food and Drug Administration (FDA) has approved these medicines for treating type 2 diabetes and obesity. However, you may wonder: What if you have elevated blood sugar — also called prediabetes — but don’t have type 2 diabetes or obesity? Could these medicines also make sense for you?

Explore comprehensive guides on hundreds of common and rare diseases and conditions from the experts at Mayo Clinic.

Dec 2, 2022 · Know how obesity can affect your pregnancy. Learn about possible complications and specialized care you might need.

Feb 14, 2023 · There has been a worldwide increase in obesity and its complications, such as diabetes. Alcohol use also has increased during the COVID-19 pandemic, which has added to the prevalence of liver problems over the last decade.

Jun 7, 2023 · Mayo Clinic Health Letter. Starting at $9.99/year. Get direct access to the knowledge, wisdom, advice and practical information on healthy aging from Mayo Clinic, one of the world’s foremost health authorities.

Feb 23, 2024 · Symptoms. If you have binge-eating disorder, you may be overweight or obese, or you may be at a healthy weight. Most people with binge-eating disorder feel upset about their body size or shape no matter what the number on the scale is.

Jun 18, 2021 · Their findings, published in the journal Obesity in 2021, show that a phenotype-guided approach was associated with 1.75-fold greater weight loss after one year and the proportion of patients who lost more than 10% at one year was 79%, compared with 34% whose treatment was not phenotype guided.